In our cohort, FLT1 C/C had a trend towards significance in the entire cohort and did predict inferior PFS in IMDC intermediate risk patients.
← all excerpts
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.
1
—
—